The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.00
Bid: 316.50
Ask: 318.00
Change: 0.00 (0.00%)
Spread: 1.50 (0.474%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 319.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

5 May 2022 14:00

RNS Number : 4950K
Morgan Advanced Materials PLC
05 May 2022
 

Morgan Advanced Materials plc (the "Company")

 

RESULTS OF ANNUAL GENERAL MEETING

 

The Company confirms that all resolutions set out in the notice of its 2022 Annual General Meeting were duly passed by the requisite number of shareholders on a poll, at the meeting held on 5 May 2022.

 

The poll results of each resolution are set out below. The number of the Company's Ordinary shares carrying the right to vote at the meeting was 285,369,988. Each share carried one vote.

 

Resolution

Votes For

(see note 1)

Votes Against

(see note 1)

Votes Withheld

(see note 2)

Total Votes Cast

(excl. withheld votes)

% of total issued share capital voted (excl. withheld votes)

Number of shares

% of total voted

Number of shares

% of total voted

1. To receive the audited accounts and the Auditor's and Directors' Reports for the year ended 31 December 2021

239,431,002

100.00

8,940

0.00

1,243,926

239,439,942

83.91%

2. To approve the Directors' Remuneration Policy (as contained in the Directors' Remuneration Report for the year ended 31 December 2021)

232,033,438

96.45

8,552,394

3.55

98,036

240,585,832

84.31%

3. To approve the Directors' Remuneration Report (other than the part containing the Directors' Remuneration Policy) for the year ended 31 December 2021

238,834,239

99.27

1,747,323

0.73

102,306

240,581,562

84.31%

4. To approve the final dividend

240,679,795

100.00

3,296

0.00

777

240,683,091

84.34%

5. To re-elect Jane Aikman as a Director

238,013,857

98.90

2,658,123

1.10

11,888

240,671,980

84.34%

6. To re-elect Helen Bunch as a Director

237,585,362

98.72

3,087,630

1.28

10,876

240,672,992

84.34%

7. To re-elect Douglas Caster as a Director

235,441,566

98.23

4,236,036

1.77

1,006,266

239,677,602

83.99%

8. To re-elect Laurence Mulliez as a Director

236,433,228

98.24

4,238,442

1.76

12,198

240,671,670

84.34%

9. To re-elect Pete Raby as a Director

239,132,544

99.36

1,535,228

0.64

16,096

240,667,772

84.34%

10. To re-elect Peter Turner as a Director

238,363,491

99.04

2,307,979

0.96

12,398

240,671,470

84.34%

11. To re-elect Clement Woon as a Director

237,842,495

98.82

2,828,687

1.18

12,686

240,671,182

84.34%

12. To re-appoint Deloitte LLP as Auditor of the Company

240,202,825

99.87

315,067

0.13

165,976

240,517,892

84.28%

13. To authorise the Audit Committee of the Board of Directors to determine the Auditor's remuneration

240,653,728

99.99

19,991

0.01

10,149

240,673,719

84.34%

14. To authorise the Company and its subsidiaries to make political donations and incur political expenditure

238,164,740

98.97

2,479,513

1.03

39,615

240,644,253

84.33%

15. To authorise the Directors to allot shares

222,915,657

92.62

17,750,820

7.38

17,391

240,666,477

84.33%

16. To approve the Morgan Advanced Materials Share Plan 2022

237,660,252

98.77

2,962,503

1.23

61,113

240,622,755

84.32%

17.* To empower the Directors to generally disapply pre-emption rights up to a specified limit

226,245,943

94.02

14,398,817

5.98

39,108

240,644,760

84.33%

18.* To empower the Directors to disapply pre-emption rights in connection with acquisitions or capital investments up to a specified limit

215,309,777

89.47

25,340,684

10.53

33,407

240,650,461

84.33%

19.* To authorise the Company to purchase its own Ordinary shares up to the specified limit

239,541,525

99.56

1,060,345

0.44

81,998

240,601,870

84.31%

20.* To enable the Company to convene a general meeting (other than AGMs) on at least 14 days' notice

234,725,767

98.05

4,674,616

1.95

1,283,485

239,400,383

83.89%

 

 

In accordance with Listing Rule 9.6.2, copies of the resolutions passed by Morgan Advanced Materials plc shareholders concerning items other than ordinary business have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstorage 

 

 

Notes:

 

1. Votes "for" and "against" are expressed as a percentage of votes received. Votes "for" include those at the Chairman's discretion.

2. Votes "withheld" are not votes in law and, therefore, have not been included in the calculation of the proportion of votes "for" or "against" a resolution.

* Indicates special resolution.

 

 

Enquiries: Stephanie Mackie, Company Secretary

 

Telephone: 01753 837000

 

 

Legal Entity Identifier: I4K14LL95N2PHDL7EG85

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSIFEIEESEFI
Date   Source Headline
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding
23rd Mar 202211:01 amRNSDirector/PDMR Shareholding
22nd Mar 20225:04 pmRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSFull-year results
10th Jan 202211:30 amRNSHolding(s) in Company
15th Dec 202110:00 amRNSBlock listing Interim Review
7th Dec 202112:30 pmRNSHolding in Company
26th Nov 20213:32 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSTrading Update
18th Oct 202112:21 pmRNSDirector/PDMR Shareholding
18th Oct 202112:20 pmRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSCFO Appointment
14th Oct 20219:15 amRNSHolding in Company
11th Oct 202110:45 amRNSHolding in Company
28th Sep 20213:15 pmRNSDirector/PDMR Shareholding
17th Sep 20213:58 pmRNSDirector/PDMR Shareholding
16th Sep 202111:30 amRNSDirector/PDMR Shareholding
5th Aug 20211:39 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
15th Jun 20219:38 amRNSBlock Listing Interim Review
10th Jun 20219:18 amRNSDirector/PDMR Shareholding
27th May 20214:02 pmRNSDirector/PDMR Shareholding
25th May 20213:38 pmRNSDirector/PDMR Shareholding
11th May 202110:20 amRNSDirector/PDMR Shareholding
6th May 202111:54 amRNSResult of AGM
6th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTrading Update
31st Mar 20212:08 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.